Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lamber..crazy et al...folks....too argue over...

"I would like to see a informative pr from the company regarding their take on the SC ruling and I am very interested in knowing how many shares have been repurchased and what our float currently is"


I do not expect a "special" pr from the company regarding the SC ruling. They told Dutton to communicate, what they wanted to be communicated - eom.

Nevertheless I DO expect a June shareholder letter this week and maybe RG will explain a little about the timeline, which seems to be known, if I read this sentence from today's Dutton report correctly:

"...and the upcoming results of the USPTO patent review"

It would be nice, if he could be more precisely...lol

GLTY


Share
New Message
Please login to post a reply